Drug information provided by: Merative, Micromedex®
Luspatercept-aamt injection is used to treat anemia in patients with beta thalassemia who need regular red blood cell (RBC) transfusions.
Luspatercept-aamt injection is also used to treat anemia in patients with myelodysplastic syndromes who need regular red blood cell (RBC) transfusions and have never received an erythropoiesis stimulating agent (ESA).
Luspatercept-aamt injection is also used to treat anemia in patients with myelodysplastic syndromes with ring sideroblasts (MDS-RS) or myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T) who need regular red blood cell (RBC) transfusions. This medicine is given to patients who cannot receive erythropoiesis stimulating agent (ESA) or has received ESA but did not work well.
This medicine is to be given only by or under the immediate supervision of your doctor.
Portions of this document last updated: Feb. 01, 2024
Copyright: © Merative US L.P. 1973, 2024. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?